Drugging the gut microbiome.
Using conventional drug discovery and novel synthetic biology approaches, some investigators and companies are mining our resident microbes and their metabolites for targets in small-molecule drug programs. Ken Garber reports.
Ken
K
Garber
D002318:Cardiovascular Diseases / Q000628:therapy; D055808:Drug Discovery; D005285:Fermentation; D000069196:Gastrointestinal Microbiome; D005818:Genetic Engineering; D006801:Humans; D055442:Metabolome